P. falciparum infection rates in pregnant women attending their first antenatal care visit can be used to estimate the burden of malaria in children living in the community, according to a study led by the Barcelona Institute ...
Jul 7, 2023
0
9
Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.
Jul 5, 2023
0
1
A prospective cohort study has found that repeat testing in 48-hour intervals with a rapid antigen test (Ag-RDT) may be required to rule out SARS-CoV-2 infection. This means that people testing for SARS-CoV-2 should exercise ...
Jul 3, 2023
0
256
GSK Plc's experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that's gaining resistance to treatment.
Jun 29, 2023
0
49
What if the microbes in your gut could act as an early warning system, alerting you that you could be developing Alzheimer's disease? This might sound improbable, but recent research has found certain microbes are more common ...
Jun 25, 2023
0
21
According to the World Health Organization, each year there are approximately three million undiagnosed cases of tuberculosis (TB) globally, which are characterized as the "missing millions." In a cutting-edge study, scientists ...
Jun 22, 2023
0
51
Asymptomatic PCR testing for NHS staff, provided by the Francis Crick Institute and University College London Hospitals (UCLH) NHS Foundation Trust and its diagnostic partner Health Services Laboratories, effectively detected ...
Jun 21, 2023
0
12
Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome are debilitating conditions with similar symptoms. Neither condition has diagnostic tests or treatments approved by the Food and Drug Administration (FDA) ...
Jun 10, 2023
1
19
Thanks to the collaboration between teams from the AP-HP, the MedTech METAFORA biosystems, the Institute of Molecular Genetics of Montpellier, Cerba Healthcare, and more than 30 investigating centers coordinated by Professor ...
Jun 5, 2023
0
27
A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...
May 31, 2023
0
45
